1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
6.08%
G&A growth while AGEN reduces overhead. John Neff would investigate operational differences.
No Data
No Data available this quarter, please select a different quarter.
0.73%
Other expenses change of 0.73% while AGEN maintains costs. Bruce Berkowitz would investigate efficiency.
5.73%
Operating expenses growth while AGEN reduces costs. John Neff would investigate differences.
5.73%
Total costs growth while AGEN reduces costs. John Neff would investigate differences.
3.59%
Interest expense growth while AGEN reduces costs. John Neff would investigate differences.
No Data
No Data available this quarter, please select a different quarter.
-5.73%
EBITDA decline while AGEN shows 22.29% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
-5.73%
Operating income decline while AGEN shows 19.69% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.82%
Tax expense growth above 1.5x AGEN's 2.05%. Michael Burry would check for concerning trends.
-4.82%
Net income decline while AGEN shows 12.20% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
-5.05%
EPS decline while AGEN shows 25.25% growth. Joel Greenblatt would examine position.
-5.05%
Diluted EPS decline while AGEN shows 25.25% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.